CD26/DPP-IV inhibitors and associations with chronic lung allograft dysfunction in a multicenter cohort
The association of gliptins and CLAD is complex, but early gliptin use may help protect against CLAD if started within 90 days post-transplant and used for a prolonged period.
Authors
- Simone Passarelli (ORCID: https://orcid.org/0000-0003-1044-3393)
- A. Graham (ORCID: https://orcid.org/0000-0001-5381-5279)
- Isabelle Moneke (ORCID: https://orcid.org/0000-0002-1019-5214)
- Steven R. Hays (ORCID: https://orcid.org/0000-0002-2887-8451)
- Megan L. Neely (ORCID: https://orcid.org/0000-0002-0101-1081)
- Maria V. Grau‐Sepulveda
- Erin Tallarico (ORCID: https://orcid.org/0009-0009-5968-8384)
- Bo Yen (ORCID: https://orcid.org/0000-0003-4392-3027)
- Daniel F. Dilling (ORCID: https://orcid.org/0000-0002-9723-510X)
- Laurie D. Snyder (ORCID: https://orcid.org/0000-0002-5962-2184)
- Carli J. Lehr (ORCID: https://orcid.org/0000-0003-2846-2242)
- Grant A. Turner (ORCID: https://orcid.org/0000-0003-0735-4947)
- Elizabeth Buckley (ORCID: https://orcid.org/0000-0001-8980-1194)
- Albert Faro (ORCID: https://orcid.org/0000-0001-8408-6371)
- Jerry Kirchner
- Abigail Thaxton Ccrp
Institutions
- Cleveland Clinic (US)
- University of Freiburg (DE)
- University of California, Los Angeles (US)
- Duke University (US)
- University of California, San Francisco (US)
- Loyola University Chicago (US)
- Cystic Fibrosis Foundation (US)
- University Medical Center Freiburg (DE)
- University of California System (US)
- Clinical Research Institute (US)
- University of California San Francisco Medical Center (US)
- Duke Medical Center (US)
- Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
Publication Details
- Journal
- The Journal of Heart and Lung Transplantation
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1016/j.healun.2025.04.010
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cystic Fibrosis Foundation
- National Heart, Lung, and Blood Institute